source
- Sun Pharma halts eye-care drug production in India after regulator cited quality failuresSun Pharma has stopped manufacturing eye-care medicines at its Assam facility after Indian regulators identified failures in the company's quality management system. The company previously recalle…
- Tiziana's lower-dose foralumab cuts neuroinflammation in SPMS, but higher dose failsTiziana Life Sciences reported that its intranasal anti‑CD3 antibody, foralumab, lowered a neuroinflammation biomarker in patients with non‑active secondary progressive multiple sclerosis when give…